710-1077

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-11-17

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild AGITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-12 (study day 57.0); relationship: REMOTE

mild assessed

Mild APPLICATION SITE DERMATITIS — outcome: RECOVERED/RESOLVED; onset 2013-12-12 (study day 26.0); relationship: POSSIBLE

severe assessed

Severe ARTHRITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 1977; relationship: NONE

moderate assessed

Moderate ARTHRITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 1977; relationship: NONE

mild assessed

Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-27 (study day 41.0); relationship: POSSIBLE

Data queries

No data queries.